DexCom, Inc. (DXCM)
73.08
+0.81
(+1.12%)
USD |
NASDAQ |
Feb 20, 16:00
73.23
+0.15
(+0.21%)
After-Hours: 20:00
DexCom SG&A Expense (Quarterly) : 321.50M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| BioLife Solutions, Inc. | 14.60M |
| Abbott Laboratories | 3.129B |
| Krystal Biotech, Inc. | 41.45M |
| Boston Scientific Corp. | 1.834B |
| Insulet Corp. | 0.00 |